News
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the 'Company') announced that a new indication application (the 'Application') for the Company's trophoblast cell-surface antigen 2 (TROP2)-directed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback